# Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity

> **NCT02145689** · PHASE3 · WITHDRAWN · sponsor: **Allergan**

## Conditions studied

- Muscle Spasticity
- Stroke

## Interventions

- **BIOLOGICAL:** onabotulinumtoxinA

## Key facts

- **NCT ID:** NCT02145689
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-08
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was withdrawn prior to enrollment due to corporate decision.
- **Last updated:** 2014-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02145689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02145689, "Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02145689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*